Found: 91
Select item for more details and to access through your institution.
Leukocyte reduction in blood component therapy.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Reducing the risk for transfusion-transmitted cytomegalovirus infection.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Soybean yield response to residual NO{sub}3-N and applied N
- Published in:
- Plant & Soil, 1985, v. 84, n. 2, p. 259
- By:
- Publication type:
- Article
Are guidelines for use of gamma irradiation for the prevention of transfusion-associated graft-versus-host disease adequate for newborns?
- Published in:
- Transfusion Medicine, 1997, v. 7, n. 2, p. 172, doi. 10.1046/j.1365-3148.1997.d01-18.x
- By:
- Publication type:
- Article
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.
- Published in:
- Oncogene, 2013, v. 32, n. 11, p. 1341, doi. 10.1038/onc.2012.164
- By:
- Publication type:
- Article
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition.
- Published in:
- Oncogene, 2010, v. 29, n. 16, p. 2325, doi. 10.1038/onc.2009.510
- By:
- Publication type:
- Article
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
- Published in:
- Oncogene, 2008, v. 27, n. 6, p. 721, doi. 10.1038/sj.onc.1210679
- By:
- Publication type:
- Article
A novel Bcl-2/Bcl-X<sub>L</sub>/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
- Published in:
- Oncogene, 2007, v. 26, n. 16, p. 2374, doi. 10.1038/sj.onc.1210028
- By:
- Publication type:
- Article
Dizygotic twinning, cryptorchism, and seminoma in a sibship.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 9, p. 1918, doi. 10.1038/leu.2015.83
- By:
- Publication type:
- Article
Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 6, p. 1441, doi. 10.1038/leu.2015.11
- By:
- Publication type:
- Article
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 3, p. 727, doi. 10.1038/leu.2014.279
- By:
- Publication type:
- Article
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.
- Published in:
- 2015
- By:
- Publication type:
- letter
CSNK1α1 mediates malignant plasma cell survival.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 2, p. 510, doi. 10.1038/leu.2014.300
- By:
- Publication type:
- Article
CSNK1α1 mediates malignant plasma cell survival.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 2, p. 474, doi. 10.1038/leu.2014.202
- By:
- Publication type:
- Article
A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 1, p. 218, doi. 10.1038/leu.2014.159
- By:
- Publication type:
- Article
Gene expression profile alone is inadequate in predicting complete response in multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 11, p. 2229, doi. 10.1038/leu.2014.140
- By:
- Publication type:
- Article
A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 8, p. 1716, doi. 10.1038/leu.2014.46
- By:
- Publication type:
- Article
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 680, doi. 10.1038/leu.2013.231
- By:
- Publication type:
- Article
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 525, doi. 10.1038/leu.2013.350
- By:
- Publication type:
- Article
Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 457, doi. 10.1038/leu.2013.301
- By:
- Publication type:
- Article
Association of response endpoints with survival outcomes in multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 258, doi. 10.1038/leu.2013.220
- By:
- Publication type:
- Article
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2366, doi. 10.1038/leu.2013.194
- By:
- Publication type:
- Article
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 4, p. 780, doi. 10.1038/leu.2012.336
- By:
- Publication type:
- Article
Minor clone provides a reservoir for relapse in multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 2, p. 473, doi. 10.1038/leu.2012.226
- By:
- Publication type:
- Article
β-catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresome-autophagosome-lysosome pathway.
- Published in:
- 2012
- By:
- Publication type:
- letter
β-catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresome-autophagosome-lysosome pathway.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 5, p. 1116, doi. 10.1038/leu.2011.303
- By:
- Publication type:
- Article
Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.
- Published in:
- 2011
- By:
- Publication type:
- letter
HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 10, p. 1700, doi. 10.1038/leu.2010.173
- By:
- Publication type:
- Article
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The use of novel agents in the treatment of relapsed and refractory multiple myeloma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 10, p. 1716, doi. 10.1038/leu.2009.122
- By:
- Publication type:
- Article
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.
- Published in:
- British Journal of Haematology, 2004, v. 127, n. 2, p. 165, doi. 10.1111/j.1365-2141.2004.05188.x
- By:
- Publication type:
- Article
A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 2, p. 455, doi. 10.1046/j.1365-2141.2001.02760.x
- By:
- Publication type:
- Article
Targeted treatments to improve stem cell outcome: old and new drugs.
- Published in:
- Bone Marrow Transplantation, 2007, v. 40, n. 12, p. 1129, doi. 10.1038/sj.bmt.1705829
- By:
- Publication type:
- Article
The evolving background for high-dose treatment for myeloma.
- Published in:
- Bone Marrow Transplantation, 2007, v. 40, n. 12, p. 1097, doi. 10.1038/sj.bmt.1705867
- By:
- Publication type:
- Article
2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27.
- Published in:
- Apoptosis, 2004, v. 9, n. 2, p. 149, doi. 10.1023/B:APPT.0000018797.66067.6c
- By:
- Publication type:
- Article
Mechanisms of cell death and survival in multiple myeloma (MM): Therapeutic implications.
- Published in:
- Apoptosis, 2003, v. 8, n. 4, p. 337, doi. 10.1023/A:1024164700094
- By:
- Publication type:
- Article
Apoptosis in multiple myeloma: Therapeutic implications.
- Published in:
- Apoptosis, 2001, v. 6, n. 1, p. 47, doi. 10.1023/A:1009620027205
- By:
- Publication type:
- Article
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 9, p. 1679, doi. 10.1038/leu.2009.83
- By:
- Publication type:
- Article
The research mission in myeloma.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Bone marrow microenvironment and the identification of new targets for myeloma therapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 10, p. 1925, doi. 10.1038/leu.2008.174
- By:
- Publication type:
- Article